Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
15,13 USD | -1,75% | 0,00% | -6,49% |
30/04 | NEOGENOMICS, INC. : Needham & Co. geeft koopadvies | ZM |
30/04 | Neogenomics zoekt M&A | CI |
Omzet 2024 * | 656 mln. 603 mln. | Omzet 2025 * | 719 mln. 661 mln. | Marktkapitalisatie | 1,93 mld. 1,78 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -72 mln. -66,19 mln. | Nettowinst (verlies) 2025 * | -47 mln. -43,21 mln. | EV/omzet 2024 * | 3,35 x |
Nettoschuld 2024 * | 265 mln. 244 mln. | Nettoschuld 2025 * | 238 mln. 219 mln. | EV/omzet 2025 * | 3,02 x |
K/w-verhouding 2024 * |
-26,5
x | K/w-verhouding 2025 * |
-41,9
x | Werknemers | 2.100 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,82% |
Recentste transcriptie over NeoGenomics, Inc.
1 dag | -1,75% | ||
Lopende maand | +8,69% | ||
1 maand | +10,04% | ||
3 maanden | +1,54% | ||
6 maanden | -14,33% | ||
Lopend jaar | -6,49% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chris Smith
CEO | Chief Executive Officer | 61 | 15-08-22 |
Lynn Tetrault
CHM | Chairman | 61 | 12-06-15 |
Jeffrey Sherman
DFI | Director of Finance/CFO | 58 | 07-12-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Bruce Crowther
BRD | Director/Board Member | 72 | 22-10-14 |
Michael Kelly
BRD | Director/Board Member | 67 | 15-07-20 |
Chris Smith
CEO | Chief Executive Officer | 61 | 15-08-22 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
1.43% | 14 M€ | -3,17% | ||
0.97% | 11 M€ | -6,03% | - | |
0.29% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
15-05-24 | 15,13 | -1,75% | 1 091 515 |
14-05-24 | 15,4 | -1,47% | 583 110 |
13-05-24 | 15,63 | -0,89% | 403 619 |
10-05-24 | 15,77 | +1,74% | 601 099 |
09-05-24 | 15,5 | +2,45% | 460 358 |
uitgestelde koers Nasdaq, 15 mei 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-6,49% | 1,93 mld. | |
-15,96% | 8,57 mld. | |
+67,50% | 4,3 mld. | |
-4,03% | 2,46 mld. | |
-42,54% | 2,31 mld. | |
-20,45% | 1,53 mld. | |
-41,24% | 1,2 mld. | |
+10,26% | 1,14 mld. | |
+18,74% | 986 mln. | |
-10,60% | 941 mln. |